z-logo
open-access-imgOpen Access
Oral drugs against COVID-19
Author(s) -
Gerd Mikus,
Kathrin I. Foerster,
Theresa Terstegen,
Cathrin J. Vogt,
André Said,
Martin Schulz,
Walter E. Haefeli
Publication year - 2022
Publication title -
deutsches ärzteblatt international
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 60
ISSN - 1866-0452
DOI - 10.3238/arztebl.m2022.0152
Subject(s) - ritonavir , medicine , drug , drug interaction , pharmacology , covid-19 , medline , approved drug , cyp3a , intensive care medicine , cytochrome p450 , viral load , virology , virus , disease , metabolism , antiretroviral therapy , infectious disease (medical specialty) , law , political science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom